Multi-center, Investigator-initiated trial for evaluating the efficacy and safety of D+storm stent
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0005532
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
1) Adult over 19 years old
2) Patients treated with D+storm sirolimus elutating coronary stent
3) Patients who agree to a Protocol and a clinical follow-up survey plan and who have agreed in writing to a patient consent form approved by the clinical Institutional Review Board of each research institute.
1) Patients treated with drug elution stents other than D+ storm
2) Patients with a life expectancy of less than a year
3) A psychogenic shock patient
4) Patients with a left ventricular ejection fraction of less than 30%
5) A woman of a possible pregnancy age who plans to conceive during this study.
6) Patients who are judged to be inappropriate to participate in the study by other investigator
7) Subjects who are scheduled to undergo surgery that requires the discontinuation of antiplatelet drugs within 12 months of registration.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Coronary artery intervention procedure death at the point of 12 months' time, myocardial infarction or Compound clinical events in the occurrence of Target Lesion Revaccination (TLR)
- Secondary Outcome Measures
Name Time Method All deaths.;Cardiac death.;Myocardial infarction (MI);Target vessel revascularization (TVR);Target Lesion revascularization (TLR);Stent thrombosis (ARC standard);Successfully procedure